Načítá se...
Miltefosine Rescue Treatment for Visceral Leishmaniasis Relapse Patient
We report the first case of miltefosine rescue treatment carried out for visceral leishmaniasis (VL) relapse patient. Despite undergoing treatment regimens of liposomal amphotericin B (LAMB) 5 mg/kg (standard: 10 mg/kg) daily for 3 days during the first episode followed by LAMB 5 mg/kg stat and paro...
Uloženo v:
| Vydáno v: | Case Rep Infect Dis |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6745118/ https://ncbi.nlm.nih.gov/pubmed/31565448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3634568 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|